StreetAccount Drug Database provides detailed information on prescription drugs and biologics

Biotech and Pharmaceuticals are two of the top performing industries in the Russell 3000 so far in 2014. The SPDR Biotech ETF is up over 23% YTD and the SPDR Pharmaceuticals ETF is up over 12% YTD. Firms like Regeneron Pharmaceuticals (REGN) witnessed a 15% spike in their stock price during the month of February, thanks in part to positive trial results released on their drug, Eylea.

StreetAccount’s Drug Database provides relevant and current information on prescription drugs, biologics, and pipeline candidates. Users can easily access information to aid in their research such as annual drug revenues, partner relationships, competitive drugs, legal actions, and patent expirations. Search by brand name, active ingredient, company, or class of drug to quickly locate information most relevant to you. StreetAccount analysts monitor company press releases, SEC filings, drug pipeline updates, and FDA data to maintain the database. Most updates occur within 24 hours of news being released via these various avenues.